ICU Acquired Weakness: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 8: | Line 8: | ||
== Introduction == | == Introduction == | ||
Critical patients often develop neuromuscular disorders such as Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM) called Intensive Care Unit Acquired weakness (ICUAW).<ref>Vanhorebeek I, Latronico N, Van den Berghe G. [https://link.springer.com/article/10.1007/s00134-020-05944-4 ICU-acquired weakness.] Intensive Care Medicine. 2020 Feb 19:1-7.</ref><ref name=":0">Judemann K, Lunz D, Zausig YA, Graf BM, Zink W. [https://www.ncbi.nlm.nih.gov/pubmed/22006117 Intensive care unit-acquired weakness in the critically ill: critical illness polyneuropathy and critical illness myopathy]. Der Anaesthesist. 2011 Oct;60(10):887-901.</ref> One of ICUAW's implications is that it causes generalized muscle weakness with more affectation on the limbs and respiratory muscles, leading to delays in mobilization and prolongation of hospitalization.<ref name=":0" /><ref>Hermans G, Van den Berghe G. [https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0993-7#Sec1 Clinical review: intensive care unit acquired weakness]. Critical care. 2015 Dec;19(1):274.</ref> There are several diseases that make people with illness worsen to the extent of need for ICU use. One of these diseases is COVID-19, which affects the respiratory system and leaves a person with this condition using a ventilator or ICU. Knowledge of ICUAW among clinicians such as physiotherapists will therefore enhance effective delivery of healthcare to ICU patients such as patient with COVID 19. This paper will therefore examine the literature on ICUAW and mamagement, which will include the role of physiotherapy. | Critical ill patients often develop neuromuscular disorders such as Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM) called Intensive Care Unit Acquired weakness (ICUAW).<ref>Vanhorebeek I, Latronico N, Van den Berghe G. [https://link.springer.com/article/10.1007/s00134-020-05944-4 ICU-acquired weakness.] Intensive Care Medicine. 2020 Feb 19:1-7.</ref><ref name=":0">Judemann K, Lunz D, Zausig YA, Graf BM, Zink W. [https://www.ncbi.nlm.nih.gov/pubmed/22006117 Intensive care unit-acquired weakness in the critically ill: critical illness polyneuropathy and critical illness myopathy]. Der Anaesthesist. 2011 Oct;60(10):887-901.</ref> One of ICUAW's implications is that it causes generalized muscle weakness with more affectation on the limbs and respiratory muscles, leading to delays in mobilization and prolongation of hospitalization.<ref name=":0" /><ref>Hermans G, Van den Berghe G. [https://ccforum.biomedcentral.com/articles/10.1186/s13054-015-0993-7#Sec1 Clinical review: intensive care unit acquired weakness]. Critical care. 2015 Dec;19(1):274.</ref> There are several diseases that make people with illness worsen to the extent of need for ICU use. One of these diseases is COVID-19, which affects the respiratory system and leaves a person with this condition using a ventilator or ICU. Knowledge of ICUAW among clinicians such as physiotherapists will therefore enhance effective delivery of healthcare to ICU patients such as patient with COVID 19. This paper will therefore examine the literature on ICUAW and mamagement, which will include the role of physiotherapy. | ||
== Pathophysiological Process == | == Pathophysiological Process == | ||
| Line 35: | Line 35: | ||
== References == | == References == | ||
<references /> | |||
Revision as of 13:22, 8 April 2020
Original Editor - Tolulope ADENIJI.
Top Contributors - Tolulope Adeniji, Lucinda hampton, Vidya Acharya, Kim Jackson and Natalie Patterson
Introduction[edit | edit source]
Critical ill patients often develop neuromuscular disorders such as Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM) called Intensive Care Unit Acquired weakness (ICUAW).[1][2] One of ICUAW's implications is that it causes generalized muscle weakness with more affectation on the limbs and respiratory muscles, leading to delays in mobilization and prolongation of hospitalization.[2][3] There are several diseases that make people with illness worsen to the extent of need for ICU use. One of these diseases is COVID-19, which affects the respiratory system and leaves a person with this condition using a ventilator or ICU. Knowledge of ICUAW among clinicians such as physiotherapists will therefore enhance effective delivery of healthcare to ICU patients such as patient with COVID 19. This paper will therefore examine the literature on ICUAW and mamagement, which will include the role of physiotherapy.
Pathophysiological Process[edit | edit source]
add text here relating to the mechanism of injury and/or pathology of the condition
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition
Diagnostic Procedures[edit | edit source]
add text here relating to diagnostic tests for the condition
Outcome Measures[edit | edit source]
add links to outcome measures here (see Outcome Measures Database)
Management / Interventions[edit | edit source]
add text here relating to management approaches to the condition
Resources[edit | edit source]
add appropriate resources here
References[edit | edit source]
- ↑ Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Medicine. 2020 Feb 19:1-7.
- ↑ 2.0 2.1 Judemann K, Lunz D, Zausig YA, Graf BM, Zink W. Intensive care unit-acquired weakness in the critically ill: critical illness polyneuropathy and critical illness myopathy. Der Anaesthesist. 2011 Oct;60(10):887-901.
- ↑ Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Critical care. 2015 Dec;19(1):274.
